India Glycols Ltd
NSE: INDIAGLYCO BSE: 500201
Established in 1988, India Glycols Ltd. is engaged in the manufacturing of green technology-based bulk, specialty & performance chemicals, and natural gums, spirits, industrial gases, sugar, and nutraceuticals. [1][2]
₹1,005
52W: ₹792 — ₹1223
PE 23.7 · Book ₹379 · +165% vs bookMarket Cap₹6,733 Cr
Stock P/E23.7Price to Earnings
ROCE13.4%Return on Capital
ROE12.8%Return on Equity
Div. Yield0.75%Face Value ₹5
Strengths
- +Company has delivered good profit growth of 27.4% CAGR over last 5 years
- +Company has been maintaining a healthy dividend payout of 17.1%
Weaknesses
- −Stock is trading at 2.58 times its book value
- −Company has a low return on equity of 10.8% over last 3 years.
Shareholding Pattern
Promoters59.63%
FIIs2.27%
DIIs5.19%
Public32.91%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 61.02% | 61.02% | 61.02% | 61.02% | 61.02% | 61.02% | 59.63%▼1.4 | 59.63% |
| FIIs | 1.75% | 2.9%▲1.1 | 2.44%▼0.5 | 2.24%▼0.2 | 3.44%▲1.2 | 2.62%▼0.8 | 2.42%▼0.2 | 2.27%▼0.1 |
| DIIs | 0.09% | 1.93%▲1.8 | 2%▲0.1 | 0.91%▼1.1 | 1.39%▲0.5 | 1.34%▼0.0 | 5.22%▲3.9 | 5.19%▼0.0 |
| Public | 37.15% | 34.15%▼3.0 | 34.54%▲0.4 | 35.82%▲1.3 | 34.15%▼1.7 | 35.04%▲0.9 | 32.72%▼2.3 | 32.91%▲0.2 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 904 | 924 | 968 | 961 | 975 | 863 | 1,040 | 1,091 | 1,102 | 978 |
| Expenses | 801 | 818 | 846 | 845 | 851 | 719 | 893 | 932 | 926 | 814 |
| Operating Profit | 103 | 105 | 123 | 116 | 124 | 144 | 148 | 158 | 176 | 164 |
| OPM % | 11% | 11% | 13% | 12% | 13% | 17% | 14% | 14% | 16% | 17% |
| Net Profit | 38 | 38 | 47 | 39 | 44 | 50 | 53 | 54 | 65 | 110 |
| EPS ₹ | 6.11 | 6.1 | 7.55 | 6.37 | 7.08 | 8.13 | 8.54 | 8.71 | 9.74 | 16.45 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹4,211Cr, up 11.8% YoY. OPM at 15%.
Debt Position
Borrowings at ₹1,691Cr. Debt-to-equity ratio: 0.68x. Moderate leverage.
Capex Cycle
CWIP at ₹37Cr (1% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 5.19% (+3.22pp change). FIIs: 2.27% (+1.11pp change). Promoters hold 59.63%.
Margin & Efficiency
ROCE improving from 4% (Mar 2015) to 13% (Mar 2026). Working capital days: -50.
Valuation
PE 23.7x with 13.4% ROCE. Price is 165% above book value of ₹379. Dividend yield: 0.75%.
Recent Announcements
- Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th May, 2026 14 May - India Glycols approved FY26 audited results; standalone PAT Rs 282.33 crore, consolidated PAT Rs 292.76 crore.
- Announcement under Regulation 30 (LODR)-Change in Management 14 May - Board re-appointed S.S. Kothari Mehta & Co. LLP and R.J. Goel & Co. as auditors for FY 2026-27.
- Outcome Of Board Meeting Held On 14Th May, 2026 14 May
- Intimation Of Q4 & Full Year FY26 Earnings Conference Call 7 May - India Glycols will hold Q4 and FY26 earnings conference call on 18 May 2026 at 16:00 IST.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7 May - Earnings Conference Call for Q4 & Full Year FY26 will be held on Monday, 18th May, 2026 at 16.00 Hrs. (IST), as per the enclosed …
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse